,,iv #aah? ,,congress #b;d ,session ,h4 ,,res4 #adie ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,septemb] #bd1 #bjbd,mr4 ,davis ( ,ill9ois 7= himself1 ,mr4 ,burgess1 ,ms4 ,lee ( ,cali=nia1 ,ms4 ,sewell1 ,ms4 ,tlaib1 ,ms4 ,kelly ( ,ill9ois1 ,ms4 ,norton1 ,mr4 ,johnson ( ,georgia1 ,ms4 ,b>ragn1 ,ms4 ,williams ( ,georgia1 ,mr4 ,cleav]1 ,ms4 ,plaskett1 ,ms4 ,bu%1 ,ms4 ,cl>ke ( ,new ,york1 ,mr4 ,bi%op ( ,georgia1 ,mr4 ,k5n$y1 ,mr4 ,c>son1 ,mr4 ,soto1 ,mr4 ,amo1 & ,ms4 ,adams7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ,septemb] #bjbd z ,sickle ,cell ,disease ,aw>5ess ,mon? 9 ord] to educate communities across ! ,unit$ ,/ates ab\t sickle cell disease & ! ne$ = rese>*1 e>ly detection me?ods1 effective treatm5ts1 & prev5tative c>e programs ) respect to complications f sickle cell disease & conditions relat$ to sickle cell disease4 ,:]eas sickle cell disease 7ref]r$ to 9 ?is preamble z ,,scd7 is an inh]it$ blood disord] t is a major heal? problem 9 ! ,unit$ ,/ates & worldwide2 ,:]eas ,,scd results f an individual hav+ #b copies ( a sickle cell g5e1 #a inh]it$ f ea* biological p>5t2 ,:]eas ,,scd results 9 ! production ( abnormally %ap$ r$ blood cells2 ,:]eas ,,scd causes episodes ( consid]able pa9 9 ! arms1 legs1 *e/1 & abdom5 ( an individual2 ,:]eas ,,scd affects an e/imat$ #ajj1jjj individuals 9 ! ,unit$ ,/ates2 ,:]eas1 approximately #b1jjj babies are born ) ,,scd ea* ye> 9 ! ,unit$ ,/ates1 ) ! disease occurr+ 9 approximately #a 9 #cfe newborn ,african-,am]ican infants & #a 9 #af1cjj newborn ,hispanic-,am]ican infants1 & ,,scd c be f\nd 9 individuals ( ,m$it]ranean1 ,middle ,ea/]n1 ,asian1 & ,indian orig92 ,:]eas m ?an #c1jjj1jjj individuals 9 ! ,unit$ ,/ates h a s+le copy ( ! sickle cell g5e1 ref]r$ to z sickle cell trait1 & #a 9 #ac ,african ,am]icans c>ries ! trait2 ,:]eas sickle cell trait is f\nd 9 #ajj1jjj1jjj p worldwide1 & affects p ( ,african1 ,middle ,ea/]n1 ,s\? ,asian1 ,hispanic1 & s\!rn ,european ,caucasian desc5t2 ,:]eas !re is a #a 9 #d *ance t a *ild born to p>5ts :o bo? h ! sickle cell trait w h ! disease2 ,:]eas ! life expectancy ( an individual ) ,,scd 9 ! ,unit$ ,/ates is (t5 sev]ely limit$ to an av]age ( #ee ye>s = a woman & #di ye>s = a man2 ,:]eas1 accord+ to a #bjbb publication1 ! av]age lifetime co/ = individuals mo/ sev]ely impact$ by ,,scd ranges betwe5 #d1bjj1jjj to #f1bjj1jjj p] pati5t2 ,:]eas1 9 #bjbj1 ! ,national ,academies ( ,sci5ces1 ,eng9e]+1 & ,m$ic9e develop$ a compreh5sive ,/rategic ,plan & ,bluepr9t = ,action to ,address ,sickle ,cell ,disease1 :i* cit$ ! ne$ = new innovative !rapies z well z to address b>ri]s t may impact deliv]y & access to approv$ treatm5ts2 ,:]eas !re are approv$ g5etic !rapy te*nologies1 includ+ g5e edit+1 t c modify a pati5t's own hematopoietic /em cells ) ! goal ( ! pati5t be+ able to g5]ate heal?y r$ blood cells to prev5t sickle cell crisis2 ,:]eas1 :ile hematopoietic /em cell transplantation is curr5tly ! only cure = ,,scd & advances 9 treat+ ! associat$ complications ( ,,scd h occurr$1 m rese>* is ne$$ to f9d widely available treatm5ts to help individuals ) ,,scd2 ,:]eas ! ,sickle ,cell ,disease ,association ( ,am]ica has be5 ! national voice = ,,scd1 work+ ) m ?an #ej community-bas$ organizations & affiliates s]v+ ov] #ejj1jjj *ildr51 adults1 & c>egiv]s impact$ by ,,scd2 & ,:]eas ,septemb] #bjbd has be5 designat$ z ,sickle ,cell ,disease ,aw>5ess ,mon? 9 ord] to educate communities across ! ,unit$ ,/ates ab\t ,,scd1 includ+ e>ly detection me?ods1 effective treatm5ts1 & prev5tative c>e programs ) respect to complications f ,,scd & conditions relat$ to ,,scd3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 recognizes ! important "w ( ! ,sickle ,cell ,disease ,association ( ,am]ica 9 rais+ aw>5ess ( sickle cell disease1 support+ pati5ts & families ) ! disease1 & work+ t[>d f9d+ a cure = ?is deva/at+ disease2 7#b7 supports ! goals & ideals ( ,sickle ,cell ,disease ,aw>5ess ,mon?2 7#c7 commits to ensur+ equitable access among economic1 racial1 & e?nic gr\ps to new treatm5ts 9 ord] to improve heal? outcomes = ^? ) sickle cell disease2 7#d7 calls on ! ,dep>tm5t ( ,heal? & ,human ,s]vices to create policy solutions aim$ at elim9at+ b>ri]s to equitable access = specializ$ treatm5t & innovative sickle cell disease !rapies1 includ+ cell1 g5e1 & g5e-edit+ !rapies1 9 ! ,m$icaid & ,m$ic>e sy/em = pati5ts :o ne$ !m mo/2 7#e7 calls on ! ,national ,in/itutes ( ,heal? to increase fund+ = rese>* on treatm5ts & cures = sickle cell disease2 7#f7 enc\rages ! p ( ! ,unit$ ,/ates to hold appropriate programs1 ev5ts1 & activities dur+ ,sickle ,cell ,disease ,aw>5ess ,mon? to raise public aw>5ess (-- 7,a7 sickle cell disease trait2 7,b7 prev5tative c>e programs1 treatm5ts1 & o!r pati5t s]vices = ^? suff]+ f sickle cell disease2 7,c7 complications f sickle cell disease2 & 7,d7 conditions relat$ to sickle cell disease2 7#g7 enc\rages ! ,presid5t ( ! ,unit$ ,/ates to =m a ,sickle ,cell ,disease ,int]ag5cy ,cab9et1 :i* w\ld be conv5$ by ! ,:ite ,h\se1 to beg9 work+ t[>d policies t w support equitable & appropriate access to innovative sickle cell disease !rapies1 by br++ toge!r dep>tm5ts & ag5cies across ! ,f$]al ,gov]nm5t to address sickle cell disease on multiple fronts1 includ+-- 7,a7 ! ,dep>tm5t ( ,heal? & ,human ,s]vices2 7,b7 ! ,dep>tm5t ( ,vet]ans ,affairs2 7,c7 ! ,national ,in/itutes ( ,heal?2 7,d7 ! ,food & ,drug ,adm9i/ration2 & 7,e7 ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices2 & 7#h7 urges t ! options to be consid]$ by ! ,sickle ,cell ,disease ,int]ag5cy ,cab9et n only address access to pot5tial future curative treatm5ts1 b also address ! bias t ^? ) sickle cell disease cont9ue to face )9 ! ,unit$ ,/ates heal? c>e sy/em4